Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus.
Saved in:
| Title: | Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus. |
|---|---|
| Authors: | Walker CS; School of Biological Sciences, University of Auckland, Auckland, New Zealand., Aitken JF; School of Biological Sciences, University of Auckland, Auckland, New Zealand., Vazhoor Amarsingh G; School of Biological Sciences, University of Auckland, Auckland, New Zealand., Zhang S; School of Biological Sciences, University of Auckland, Auckland, New Zealand., Cooper GJS; School of Biological Sciences, University of Auckland, Auckland, New Zealand. g.cooper@auckland.ac.nz.; Department of Pharmacology, Medical Sciences Division, University of Oxford, Oxford, UK. g.cooper@auckland.ac.nz.; School of Medical Sciences, Division of Cardiovascular Sciences, University of Manchester, Manchester, UK. g.cooper@auckland.ac.nz. |
| Source: | Nature reviews. Endocrinology [Nat Rev Endocrinol] 2025 Aug; Vol. 21 (8), pp. 482-494. Date of Electronic Publication: 2025 May 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500078 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-5037 (Electronic) Linking ISSN: 17595029 NLM ISO Abbreviation: Nat Rev Endocrinol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
